### Tutorial of brachytherapy simulations using TOPAS
[TOPAS](http://www.topasmc.org/) is a toolkit that performs advanced Monte Carlo simulations of all forms of radiation therapy setups. The volumetric source enables accurate brachytherapy simulations. The TOPAS version 3.7 includes a brachytherapy package of source models and a track-lenght estimator for dose scoring [(link)](https://topas.readthedocs.io/en/latest/examples-docs/Brachytherapy/index.html). This tutorial gives some insights on how the sources are modeled and some common simulation setups (TG-43 parameters, MBDCA test case 1). Additionally, the TOPAS Time Feature System is described and used to simulate a prostate case.

For any presentation or publication using the track-length estimator or brachytherapy related calculation, please cite the following published works:

* Francisco Berumen, Yunzhi Ma, José Ramos-Méndez, Joseph Perl, and Luc Beaulieu. "Validation of the TOPAS Monte Carlo toolkit for HDR brachytherapy simulations", Brachytherapy (2021) https://doi.org/10.1016/j.brachy.2020.12.007 
* Audran Poher, Francisco Berumen, Yunzhi Ma, Joseph Perl, and Luc Beaulieu. "Characterization of LDR brachytherapy sources using the TOPAS Monte Carlo toolkit", COMP annual meeting 2021.

#### Introduction to TOPAS and example 1 (cylindrical volumetric source)
<p align="center">
<iframe width="560" height="315" src="https://www.youtube.com/embed/cNhewJFxeSE" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
 </p>

#### Example 2 (TG 186 source and test case 1)
<p align="center">
<iframe width="560" height="315" src="https://www.youtube.com/embed/F2Kt8UpuwDQ" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
 </p>

#### Example 3 (Best 2335 Pd-103 source, air-kerma strength, and dose-rate constant)

#### Example 4 (Time Feature System and prostate case)
